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BACKGROUND
Asthma and allergic disorders are of global concern, with asthma
estimated to affect 334 million people and 14% of children
worldwide.1,2 Although the prevalence of asthma may have
plateaued at ~ 8–12% in some economically developed countries,
the global burden remains substantial.1,3,4 Although the preva-
lence of allergic disorders in childhood, such as atopic eczema and
allergic rhinitis, varies substantially,5,6 the prevalence of atopic
eczema appears to be increasing in Europe, Asia and Africa.7
In addition to genetic predisposition,8 urbanisation,2 reduced
gastrointestinal ﬂora biodiversity in infancy,9 early-life exposure to
cigarette smoke,10 allergens11 and reduced exposure to respira-
tory infections12 are established risk factors for the development
of asthma and allergy in childhood. A recent randomised
controlled clinical trial has also demonstrated early introduction
of peanuts into infants’ diets to be protective against subsequent
peanut allergy.13 However, many factors remain unclear, and
discerning causal pathways and potential targets for intervention
is part of the World Health Organization’s strategy for the
prevention and control of asthma and allergy.2
There is evidence that the susceptibility for developing asthma
and allergy is established in utero.14–17 Certain prenatal exposures
are known to inﬂuence fetal development, including alcohol,
smoking, illicit drugs and teratogenic medications.18 The concept
of fetal programming describes how intrauterine factors can have
an impact on subsequent offspring’s physiology and
development,19 affecting the risk of chronic diseases later
in life.18 Childhood asthma and allergy are thought to be
similarly inﬂuenced,20 as adaptive immunity develops prenatally
with allergen-speciﬁc immune responses demonstrable in
newborns.15,16,21 Umbilical cord blood has been shown to contain
fetally derived immunoglobulin E.14,16
Prenatal psychosocial stress, mediated through increased
activity of the hypothalamic–pituitary axis, has been postulated
as an intrauterine exposure that may inﬂuence asthma and allergy
susceptibility in the offspring.12 The hypothalamic–pituitary axis is
a biochemical pathway in which hormones secreted by the
hypothalamus and pituitary gland in the brain stimulate the
release of cortisol, adrenaline and noradrenaline from the adrenal
glands in the abdomen.22 During pregnancy, these substances can
be transmitted to the fetus and inﬂuence its development.18,23
Maternal prenatal psychosocial stress increases the risk of
prematurity,18 low birthweight,18 offspring neurodevelopmental
and cognitive delay, attention-deﬁcit hyperactivity disorder,
and other mental health disorders in both animals and
humans.18,19,22,23–25 Maternal prenatal psychosocial stress may
also cause epigenetic effects with DNA methylation and altered
gene expression in the placenta, although the signiﬁcance of this
has yet to be determined.25 In addition, there is some evidence
that prenatal stress exposure can inﬂuence the composition of
offspring’s intestinal microbiota and also result in increased
susceptibility to asthma.26
Animal studies have demonstrated that high levels of cortisol
generated by prenatal psychosocial stress can increase airway
responsiveness in the offspring27–29 and potentiate cell differ-
entiation from T-helper cell-type 1 (Th1) to Th2 phenotype.
Epidemiological studies have now investigated the potential
impact of different indicators of maternal psychosocial stress
during pregnancy, including bereavement,30–32 exposure to
natural disasters,33 anxiety and depression symptoms,34,35 on
the risk of asthma and allergy in the offspring. However, to better
appreciate the underlying evidence base on the role of
psychosocial stress in the development of asthma and allergy in
the offspring, it is important to undertake a synthesis of primary
studies that have emerged on this topic. This will provide the
opportunity to identify key indicators of psychosocial stress that
may inﬂuence the risk of asthma and allergy in children and the
effects of which may be modiﬁed through development of
evidence-based and tailored primary prevention interventions.
AIMS
The aim of the study is to identify, critically appraise and
synthesise primary studies investigating the role of maternal
prenatal psychosocial stress and adverse life events in the
development of asthma and allergy in the offspring.
METHODS
This protocol has been developed in line with the Preferred
Reporting Items for Systematic reviews and Meta-analysis Protocols
(PRISMA-P) guidance36 and draws on the Cochrane Public Health
Group’s guideline for developing a systematic review protocol.37
Study types
The following study types will be considered for inclusion:
experimental studies (i.e., randomised controlled trials, quasi-
randomised controlled trials, controlled clinical trials, controlled
1Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh,
UK and 2School of Health Sciences, University of Tampere, Tampere, Finland.
Correspondence: C Flanigan (catherineﬂanigan@nhsmail.net)
Received 6 October 2015; revised 26 March 2016; accepted 1 April 2016
www.nature.com/npjpcrm
All rights reserved 2055-1010/16
© 2016 Primary Care Respiratory Society UK/Macmillan Publishers Limited
before-and-after studies and interrupted time-series designs);
both retrospective and prospective cohort studies; case–control
studies; and cross-sectional studies. Reviews, case studies, case
series and animal studies will be excluded.
Participants
Participants will include pregnant women and their offspring of
any age.
Exposure
There is no single deﬁnition of psychosocial stress; for the
purposes of this study, it is an encompassing term describing any
element of our social environment or individual emotional state
that places greater demands on us than we can easily adjust to.38
To reﬂect the diversity of factors that constitute psychosocial
stress, all indicators of acute or chronic stressors or negative life
events are eligible for inclusion. From a scoping literature search,
the following examples of psychosocial stress are anticipated:
depression or anxiety disorder, pregnancy-related anxiety,24
problems with pregnancy,30 poor maternal–fetal attachment,34
issues with existing children,30 exposure to violence, discrimina-
tion or prejudice,39 ﬁnancial problems, residential move30 or
housing issues,39 daily stressors, or generalised psychological
stress or distress.35 Sources of adverse life events include
bereavement, natural disasters,33 separation, divorce or marital
problems, involuntary job loss for mother or partner and
homelessness.
Outcomes
Primary outcomes will include any allergic disorder as deﬁned by
the World Allergy Organisation in their recommendations in
nomenclature; this includes asthma, as over 80% of cases are
allergic in aetiology.40 The following are the primary outcomes:
asthma, atopic dermatitis/eczema, atopic sensitisation, food
allergy, allergic rhinitis, urticaria and anaphylaxis.
All primary outcomes, with the exception of atopic sensitisation,
are deﬁned either by physician assessment within the study or by
the self-report of a physician diagnosis. This reﬂects the use of
clinical diagnosis as the primary method of diagnosis of allergic
conditions. In addition, asthma diagnosis through the use of
airway function tests including peak expiratory ﬂow, FEV1 (forced
expiratory volume in 1 s), forced vital capacity, forced expiratory
ﬂow rate or alternative age-appropriate pulmonary function tests
(oscillometry or exhaled nitric oxide analysis) are also accepted
methods of assessment.33
Atopic sensitisation is a physiological diagnosis and is deﬁned
either by clinical assessment of skin-prick testing or measurement
of raised antigen-speciﬁc immunoglobulin E. Diagnosis of food
allergy or urticaria through clinical assessment of skin patch test or
similar method is also an accepted outcome.
Secondary outcomes will include any measure of disease
severity or impact, including frequency of asthma exacerbations,
use of asthma medications, hospitalisation for asthma, wheezing
as deﬁned by self-report or physician diagnosis34 and measures of
health-related quality of life.
Exclusion criteria
Exclusion criteria are as follows: animal studies, studies in which
the exposure was physical stress including obesity, studies in
which low socioeconomic status alone is the exposure of interest
and studies that do not clearly distinguish between prenatal and
postnatal stress.
Study identiﬁcation
The following databases will be searched for relevant studies from
1960 to the present day: MEDLINE, EMBASE, Cochrane Library,
Web of Science, Scopus, Global Health and Cab International;
World Health Organization global library; PsychINFO, CINAHL,
AMED, National Health Service Evidence Health Information
Resources and Google Scholar. The following databases for
international conference proceedings will also be searched:
Conference Proceedings Citation Index via Web of Knowledge
and Zetoc via British Library. Reference lists of eligible articles will
be hand-checked for additional citations. International experts in
the ﬁeld will be contacted to ask for any relevant studies not
ascertained by our searches. We will also search the grey literature
through Open Grey and The Grey Literature Report. Finally, the
following registers will be searched to locate ongoing studies: The
Cochrane Central Register of Controlled Trials, International
Standardized Randomised Control Trial Number Registry, World
Health Organization International Clinical Trials Registry Platform,
ClinicalTrials.gov, Australian and New Zealand Clinic Trials Registry,
and Current Controlled Trials. Search strategies have been
developed for all intended database searches and are included
in Appendix 1.
Study selection
The records retrieved from the databases will be exported to
Endnote Library for study screening, de-duplication and overall
management of the retrieved records. All study titles and abstracts
resulting from the above searches will be independently screened
by two reviewers in respect to the inclusion and exclusion criteria
of the review; a third reviewer will arbitrate any disagreements
that are not resolved by discussion. The same process will be
repeated for full-text screening. There will be no language
restriction, and where possible efforts will be made to translate
studies found in any language other than English. Multiple reports
utilising one data set or analysed from the same study will be
reported as one study. Where data or information are missing,
every effort will be made to contact the authors requesting
additional information.
Data extraction and management
A standardised form has been developed for data extraction
(Appendix 2). The data extraction form will be piloted and revised
accordingly before use in the review. Data extraction will be
completed independently by two reviewers and discrepancies will
be resolved by referral to a third reviewer for arbitration.
Quality assessment
All studies identiﬁed will be assessed for their quality and
potential for risk of bias by two independent reviewers. Quality
and risk of bias in observational studies will be evaluated using the
Effective Public Health Practice Projec tool,41 whereas we will use
the Cochrane Effectiveness and Practice Organization of Care
guidelines for experimental studies.37 The Effective Public Health
Practice Project tool was selected, as in addition to a global rating
of study quality it also provides individual ratings for six domains
of study quality assessment enabling more detailed assessment of
strengths and weakness of individual studies. The intention is that
the quality grading of each of the six domains will then inform an
overall grading for each study. For each study, the grading for the
domains individually and the global study rating will be assigned
categories of risk of bias: low, moderate and high. Any disputes
not resolved by discussion will be arbitrated by a third reviewer.
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Analysis
All included studies will be descriptively presented in a tabular
form, summarising key features of the study design, exposure
types and methods of assessment, outcomes and methods of
assessment and an indicator of risk of bias in each study. We will
undertake both narrative synthesis of the evidence and quanti-
tative pooling (meta-analysis) of studies judged largely to be
homogeneous with regard to the clinical, methodological and
statistical aspects. Fixed-effect or random-effect meta-analyses will
be undertaken depending on an assessment of the clinical
comparability of studies and assessment of statistical
heterogeneity.42 We will quantify any heterogeneity between
studies using the I2-test, and where I2⩾ 50% we will evaluate
possible reasons for observed heterogeneity between studies by
undertaking different scenarios of subgroup analyses. In cases in
which data are available, we will undertake the following
subgroup analyses for each outcome: by type of stress exposure
or adverse life events, trimester of pregnancy at the time of
exposure, age of child at diagnosis/assessment of outcome (where
possible using the following age groups: o5, 5–12 and 412
years) and gender.
Sensitivity analyses will be undertaken by evaluating whether
the level of risk of bias in studies has any inﬂuence on the pooled
risk estimates; other potential sensitivity analyses will be under-
taken as possible with the data emanating from the studies. We
will use the funnel plot to evaluate the potential of publication
bias, and the Trim and Fill approach to explore possible inﬂuence
of publication bias on the results.37 Statistical analysis will be
undertaken using Stata Statistical Software (Release 13, StataCorp
LP, College Station, TX, USA).
Grading of the overall strength of the evidence
We will evaluate the strength and quality of the overall evidence
using the GRADE (Grading of Recommendations Assessment,
Development and Evaluation) approach.43,44 As recommended by
the GRADE system, in the ﬁrst stage, we will rate each outcome on
a scale of 1–9: scale 7–9 represents outcomes that are critical for
clinical decision-making; 4–6 for outcomes that are important but
not critical for clinical decision-making; and 1–4 for outcomes that
are not important for clinical decision-making and of lower
importance to patients. Each outcome will be grouped according
to each of these categories.43,44 In the second stage, we will appraise
the quality of the overall evidence for each outcome, which will be
presented using the GRADE evidence proﬁling table template.
Registration and reporting
This study has been registered with the University of York Centre
for Reviews and Dissemination International prospective register
of systematic reviews (PROSPERO), registration number
CRD42016036456. The review will be reported in accordance with
the PRISMA guidelines for reporting of systematic reviews and
MOOSE guidelines for meta-analysis of observational epidemiolo-
gical studies.36,45 Any amendments to the protocol and rationale
for such modiﬁcations during the systematic review will be
reported in the ﬁnal report.
The review team
Study screening, data extraction and quality assessment will be
performed independently by CF and BIN. CF has previous experi-
ence of undertaking a supervised systematic review. BIN is an
epidemiologist working in the ﬁeld of asthma and allergy and has
substantial experience in undertaking systematic reviews. AS and
CA will arbitrate any disagreements in the review process and will
provide ﬁeld expertise in synthesising the review. They are both
asthma and allergy investigators, research methodologists and have
a substantial experience in undertaking systematic reviews.
DISCUSSION
The emerging evidence, which now demonstrates that increased
levels of cortisol, resulting from prenatal psychosocial stress, can
increase airway responsiveness in the offspring26–28 and conse-
quent increased risk of allergic disorders in the offspring now
needs to be synthesised. This will provide a clearer picture of the
underlying evidence, help to identify key indicators of psychoso-
cial stress during pregnancy that may inﬂuence the susceptibility
of developing asthma and allergy in children and indicate better
pathways in tailoring potential primary prevention interventions.
RELEVANCE TO OTHER REVIEWS
Three related systematic reviews have been recently published on
the topic. Exley et al. synthesised the association between early
childhood adverse events and subsequent onset of asthma in
childhood. Hence, by considering early childhood adverse events,
their review does not address the speciﬁc question of the current
review: the role of maternal prenatal psychosocial stress and
adverse life events in the development of asthma and allergy in
the offspring.46 The study by Tibosch et al.47 did not speciﬁcally
focus on prenatal maternal stress, but considered the impact of
both the child’s psychosocial stress and that of a caregiver
(including studies on maternal prenatal stress, both parental stress
and other caregivers of the child). For studies looking at maternal
stress, the authors included only maternal mental health issues,
depression and anxiety, and not broader sources of chronic stress,
such as work-related stress or ﬁnancial difﬁculties. Furthermore,
the authors included only longitudinal studies, considered asthma
as the only outcome and searched only three databases (Medline,
Pubmed and PsychINFO) for their review, giving a possibility that
several studies not indexed in these databases might have been
missed. In our current review, by taking a more comprehensive
literature search (i.e., including the leading 13 electronic databases
and supplemented by contacting experts in the ﬁeld), we seek to
elucidate the role of maternal prenatal stress, independent of
maternal postnatal stress and the child’s early-life stress, in the
development of asthma, as well as other allergic outcomes in the
offspring. In addition, our review intends to encompass both
mental health problems and also other broader sources of
psychosocial stress that are commonly encountered during
pregnancy. Considering that no clinical trial has so far been
undertaken on the topic, we will include studies with both
retrospective and prospective designs, and where possible
undertake sensitivity analysis to evaluate whether evidence
emanating from both study design types varies.
With regard to the last and most recent review, the authors
synthesised the evidence on the impact of maternal prenatal
psychosocial stress on the onset of asthma and wheezing (as the
only outcomes) in the offspring.48 By the time we were planning
the current review, no protocol was published for that review, nor
was it registered in PROSPERO; hence, our preliminary search did
not pick it up. Nevertheless, by limiting the outcomes to only
asthma and wheezing and excluding other allergic outcomes, we
believe that there remains a research gap in this evidence base.
The impact of maternal prenatal stress on outcomes other than
asthma, such as atopic eczema, allergic rhinitis, lung function
performance and food allergies, is a key clinical and public
health question. By taking a more comprehensive approach
(i.e., including the wide range of allergic outcomes) in synthesising
the underlying evidence, the current review provides an
opportunity to compare the inﬂuence of maternal predisposition
with psychosocial stress during pregnancy on asthma and the
different allergic outcomes in the offspring. Therefore, by
including asthma and other allergic outcomes, we plan to use
the GRADE approach in appraising the overall evidence and grade
the quality of the evidence for each outcome, thus providing a
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clearer picture of the impact of maternal prenatal psychosocial
stress on asthma and speciﬁc allergic outcomes in the offspring.
Overall, through the current synthesis, we aim to identify key
indicators of prenatal psychosocial stress that have a greater
impact on offspring’s disease risk that can be amenable to primary
prevention interventions; identify potential critical window of
impact; identify and grade the evidence on the asthma and allergy
outcomes that may be of greater clinical and public concern; and
highlight existing gaps in the evidence base and suggestions for
future research.
CONCLUSIONS
Asthma and allergic conditions are common chronic disorders
with signiﬁcant health and economic costs for the individual and
for the society. Several environmental and lifestyle risk factors
have already been identiﬁed, and the role of maternal prenatal
stress and adverse life events in disease risk in the offspring is
currently gaining attention. By undertaking a comprehensive
synthesis of primary studies that have now emerged on this topic,
we can begin to better appreciate the import and quality of the
overall evidence base, thereby allowing us to identify factors that
may be amenable to primary prevention interventions.
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APPENDIX 1: Search Strategies Developed for Databases
MEDLINE
1) Stress, Psychological/
2) exp Stress Disorders, Traumatic/ or exp Stress Disorders,
Post-Traumatic/ or exp Stress Disorders, Traumatic, Acute/
3) stress*.mp.
4) exp Anxiety/ or exp Anxiety Disorders/ or anxi*.mp.
5) exp Depression/
6) depress*.mp.
7) exp Life Change Events/ or negative life events.mp.
8) adverse life events.mp.
9) natural disasters.mp. or exp Disasters/
10) exp Death
11) exp Bereavement/ or bereave*.mp
12) exp Widowhood
13) 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 12
14) exp Pregnancy/
15) pregnan*.mp
16) antenatal.mp.
17) prenatal.mp.
18) exp Prenatal Care/
19) 14 or 15 or 16 or 17 or 18
20) asthma*.mp. or exp Asthma/
21) wheez*.mp.
22) exp Respiratory Hypersensitivity/
23) exp Hypersensitivity, Immediate/ or exp Hypersensitivity/
or exp Hypersensitivity, Delayed/
24) atop*.mp.
25) allerg*.mp. or exp ‘Allergy and Immunology’/
26) exp Dermatitis, Atopic/ or dermatitis.mp.
27) exp Eczema/ or eczema.mp.
28) exp Rhinitis, Allergic/ or exp Rhinitis, Allergic, Seasonal/ or
exp Rhinitis, Allergic,Perennial/
29) exp Conjunctivitis, Allergic/
30) hayfever.mp.
31) hay fever.mp
32) rhinoconjuncivitis.mp.
33) food allerg*.mp. or exp Food Hypersensitivity/
34) exp Anaphylaxis/ or anaphyla*.mp.
35) 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30
or 31 or 32 or 33 or 34
36) 13 and 19 and 35
EMBASE
1. exp stress/
2. exp prenatal stress/ or exp acute stress disorder/
3. stress/ or stress.mp.
4. exp anxiety/ or exp ‘mixed anxiety and depression’/ or exp
anxiety disorder/ or exp generalized
anxiety disorder/
5. anxi*.mp.
6. exp depression/
7. depress*.mp.
8. Life change events.mp. or exp life event/
9. negative life events.mp.
10. adverse life event.mp.
11. exp disaster/ or natural diaster*.mp.
12. exp death/
13. exp bereavement/ or bereav*.mp.
14. exp widow/
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or
13 or 14
16. exp pregnancy/
17. pregnan*.mp.
18. exp prenatal care/
19. antenatal.mp.
20. prenatal.mp.
21. 16 or 17 or 18 or 19 or 20
22. exp asthma/ or asthma.mp.
23. exp wheezing/ or wheez*.mp.
24. respiratory hypersensitivity.mp.
25. exp immediate type hypersensitivity/ or exp delayed hyper-
sensitivity/ or exp hypersensitivity/
26. exp allergy/ or allerg*.mp.
27. atopy.mp. or exp atopy/
28. exp atopic dermatitis/ or dermatitis.mp.
29. eczema.mp. or exp eczema/
30. exp allergic rhinitis/
31. exp allergic conjunctivitis/
32. exp hay fever/
33. hayfever.mp.
34. exp rhinoconjunctivitis/
35. exp food allergy/ or food allerg*.mp.
36. food hypersensitivity.mp.
37. exp anaphylaxis/ or anaphyla*.mp.
38. urticarial*.mp
39. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
or 33 or 34 or 35 or 36 or
37 or 38
39. 15 and 21 and 39
Cochrane Library
#1 stress*
#2 MeSH descriptor: [Stress Disorders, Traumatic, Acute]
explode all trees
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#3 MeSH descriptor: [Stress Disorders, Post-Traumatic] explode
all trees
#4 MeSH descriptor: [Stress Disorders, Traumatic] explode
all trees
#5 MeSH descriptor: [Stress, Psychological] explode all trees
#6 MeSH descriptor: [Life Change Events] explode all trees
#7 ‘negative life event’
#8 ‘adverse life event’
#9 MeSH descriptor: [Disasters] explode all trees
#10 MeSH descriptor: [Death] explode all trees
#11 MeSH descriptor: [Bereavement] explode all trees
#12 MeSH descriptor: [Widowhood] explode all trees
#13 MeSH descriptor: [Pregnancy] explode all trees
#14 MeSH descriptor: [Prenatal Care] explode all trees
#15 antenatal
#16 prenatal
#17 MeSH descriptor: [Asthma] explode all trees
#18 MeSH descriptor: [Respiratory Sounds] explode all trees
#19 MeSH descriptor: [Respiratory Hypersensitivity] explode
all trees
#20 MeSH descriptor: [Hypersensitivity] explode all trees
#21 MeSH descriptor: [Hypersensitivity, Immediate] explode
all trees
#22 atop*
#23 MeSH descriptor: [Allergy and Immunology] explode
all trees
#24 allerg*
#25 MeSH descriptor: [Dermatitis, Atopic] explode all trees
#26 dermatitis
#27 MeSH descriptor: [Rhinitis, Allergic] explode all trees
#28 MeSH descriptor: [Conjunctivitis, Allergic] explode all trees
#29 hayfever
#30 ‘hay fever’
#31 rhinoconjunctivitis
#32 MeSH descriptor: [Food Hypersensitivity] explode all trees
#33 MeSH descriptor: [Anaphylaxis] explode all trees
#34 MeSH descriptor: [Urticaria] explode all trees
#35 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or
#11 or #12
#36 #13 or #14 or #15 or #16
#37 #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
or #26 or #27 or #28 or #29 or #30 or #31 or #32 or
#33 or #34
#38 #35 AND #36 AND 37
Web of Science
#40 #39 AND #20 AND#15
#39 #38 OR #37 OR #36 OR #35 OR #34 OR #33 OR #32 OR #31
OR #30 OR #29 OR #28 OR #27 OR #26 OR #25 OR #24 OR #23
OR #22 OR #21
#38 TS = urticari*
#37 TS = anaphyla*
#36 TS = ‘food hypersensitivity’
#35 TS = ‘food allerg*’
#34 TS = ‘hay fever’
#33 TS = hayfever
#32 TS = rhinoconjunctivitis
#31 TS = ‘allergic conjunctivitis’
#30 TS = ‘allergic rhinitis’
#29 TS = eczema
#28 TS = dermatitis
#27 TS = ‘dermatitis, atopic’
#26 TS = allerg*
#25 TS = atop*
#24 TS = hypersensitivity
#23 TS = ‘respiratory hypersensitivity’
#22 TS =wheez*
#21 TS = asthma*
#20 #19 OR #18 OR #17 OR #16
#19 TS = ‘prenatal care’
#18 TS = prenatal
#17 TS = antenatal
#16 TS = pregnan*
#15 #14 OR #13 OR #12 OR #11 OR #10 OR #9 OR #8 OR #7 OR
#6 OR #5 OR #4 OR #3 OR #2 OR #1
#14 TS =widow*
#13 TS = bereav*
#12 TS = death
#11 TS = ‘disaster’
#10 TS = ‘natural disaster’
#9 TS = ‘negative life event’
#8 TS = ‘adverse life event’
#7 TS = ‘life change event’
#6 TS = depress*
#5 TS = ‘anxiety, disorders’
#4 TS = anxi*
#3 TS = ‘stress, disorder’
#2 TS = ‘stress, psychological’
#1 TS = stress*
Global Health
1. exp mental stress/
2. post-traumatic stress disorder.sh.
3. stress*.mp. or exp stress/ or exp stress conditions/
4. anxiety.mp. or exp anxiety/
5. anxi*.mp.
6. exp depression/
7. depress*.mp.
8. life event.mp.
9. adverse life event.mp.
10. negative life event.mp.
11. exp disasters/ or exp natural disasters/
12. exp death/
13. bereavement.mp.
14. exp widows/ or widow*.mp.
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or
13 or 14
16. exp pregnancy/
17. pregnan*.mp.
18. antenatal.mp.
19. prenatal.mp.
20. exp prenatal care/
21. 16 or 17 or 18 or 19 or 20
22. exp bronchial asthma/ or exp asthma/ or asthma*.mp.
23. wheez*.mp.
24. exp respiratory hypersensitivity/
25. exp hypersensitivity/ or exp delayed type hypersensitivity/
or exp immediate hypersensitivity/
26. atop*.mp.
27. allergies.sh. or allerg*.mp.
28. exp atopic dermatitis/ or dermatitis.mp.
29. exp eczema/ or eczema.mp.
30. exp allergic rhinitis/
31. allergic conjunctivitis.mp.
32. hayfever.mp.
33. hay fever.mp.
34. rhinoconjunctivitis.mp.
35. food allergies.sh.
36. food hypersensitivity.mp.
37. exp anaphylaxis/
38. anaphylactoid.mp.
39. urticarial*
40. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
or 33 or 34 or 35 or 36 or 37 or 38 or 39
41. 15 and 21 and 40
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WHO Global Library
(‘Anxiety’ OR ‘Bereavement’ OR ‘Anxiety Disorders’ OR ‘Depres-
sive Disorder’ OR ‘Disasters’ OR stress* OR life event OR widow)
AND (pregnan* OR antenatal OR prenatal OR ‘prenatal care’) AND
‘Bronchial Hyperreactivity’ OR ‘Respiratory Hypersensitivity’ OR
‘Asthma’ OR ‘Rhinitis, Allergic’ OR ‘Hypersensitivity’ OR ‘Hypersen-
sitivity, Delayed’ OR ‘Hypersensitivity, Immediate’ OR ‘Conjuncti-
vitis, Allergic’ OR ‘Dermatitis, Atopic’ OR ‘Eczema’ OR food allergy
OR anaphyla*)
PsychINFO
1. exp Stress/
2. stress*.mp.
3. exp Acute Stress Disorder/ or exp Posttraumatic Stress
Disorder/
4. exp Anxiety/
5. anxi*.mp.
6. exp ‘Depression (Emotion)’/
7. depress*.mp.
8. exp Life Experiences/ or exp ‘Experiences (Events)’/
9. exp Life Changes/ or life change events.mp.
10. negative life events.mp.
11. adverse life events.mp.
12.exp Natural Disasters/ or exp Disasters/
13. exp ‘Death and Dying’/
14. bereavment.mp. or exp Bereavement/
15. exp Widows/
16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13
or 14 or 15
17. exp Pregnancy/
18. exp Prenatal Care/
19. pregnan*.mp.
20. antenatal.mp.
21. prenatal.mp.
22. 17 or 18 or 19 or 20 or 21
23. asthma.mp. or exp Asthma/
24. exp Bronchial Disorders/ or wheezing.mp.
25. hypersensitivity.mp.
26. exp Allergic Disorders/ or allergic.mp.
27. atopy.mp.
28. exp Dermatitis/
29. eczema.mp. or exp Eczema/
30. allergic rhinitis.mp.
31. allergic conjunctivitis.mp.
32. exp Hay Fever/ or hay fever.mp.
33. hayfever.mp.
34. rhinoconjunctivitis.mp.
35. food allergy.mp. or exp Food Allergies/
36. food hypersensitivity.mp.
37. exp Anaphylactic Shock/ or anaphylaxis.mp.
38. anaphylactoid.mp.
39. Urticaria*
40. 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
or 34 or 35 or 36 or 37 or 38 or 39
41. 16 and 22 and 40
CINAHL
S39 S15 AND S21 AND S38
S38 S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29
OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR
S36 OR S37
S37 (MH ‘Urticaria+’)
S36 (MH ‘Anaphylaxis’) OR ‘anaphyla*’
S35 (MH ‘Food Hypersensitivity+’) OR ‘food allerg*’
S34 ‘rhinoconjunctivitis’
S33 ""hay fever""
S32 ‘hayfever’
S31 (MH ‘Conjunctivitis, Allergic’)
S30 (MH ‘Rhinitis, Allergic, Perennial’) OR (MH ‘Rhinitis, Allergic,
Seasonal’)
S29 (MH ‘Eczema’) OR ‘eczema’
S28 (MH ‘Dermatitis, Atopic’) OR ‘dermatitis’
S27 ‘allerg*’
S26 ‘atop*’
S25 (MH ‘Hypersensitivity+’) OR (MH ‘Hypersensitivity, Immedi-
ate+’) OR (MH ‘Hypersensitivity, Delayed+’)
S24 (MH ‘Respiratory Hypersensitivity+’)
S23 ‘wheez*’ OR (MH ‘Respiratory Sounds’)
S22 (MH ‘Asthma+’) OR ‘asthma’
S21 S16 OR S17 OR S18 OR S19 OR S20
S20 ‘antenatal’
S19 ‘prenatal’
S18 (MH ‘Prenatal Care’)
S17 ‘pregnan*’
S16 (MH ‘Pregnancy+’)
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR
S10 OR S11 OR S12 OR S13 OR S14
S14 (MH ‘Widows and Widowers’) OR ‘widow*’
S13 (MH ‘Bereavement+’) OR ‘bereav*’
S12 (MH ‘Death+’)
S11 (MH ‘Natural Disasters’) OR (MH ‘Disasters+’) OR (MH ‘Mass
Casualty Incidents’)
S10 ""negative life event""
S9 ""adverse life events""
S8 (MH ‘Life Change Events+’) OR (MH ‘Life Experiences+’)
S7 ‘depress*’
S6 (MH ‘Depression+’)
S5 ‘anxi*’
S4 (MH ‘Anxiety+’) OR (MH ‘Anxiety Disorders’)
S3 ‘stress*’
S2 (MH ‘Stress Disorders, Post-Traumatic+’)
S1 (MH ‘Stress, Psychological+’)
AMED
1. exp Stress psychological/
2. exp Stress disorders post traumatic/
3. stress*.mp.
4. exp Anxiety/
5. exp Anxiety disorders/
6. exp Depression/
7. depress*.mp.
8. exp Life change events/
9. negative life event.mp.
10. exp Disasters/
11. natural disaster*.mp.
12. exp Death/
13. exp Bereavement/
14. widow*.mp.
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or
13 or 14
16. exp Pregnancy/
17. pregnan*.mp.
18. prenatal.mp.
19. antenatal.mp.
20. exp Prenatal care/
21. 16 or 17 or 18 or 19 or 20
22. exp Asthma/ or asthma*.mp.
23. wheezing.mp.
24. exp Respiratory hypersensitivity/
25. exp Hypersensitivity/
26. atop*.mp.
27. allergy.mp.
28. exp Dermatitis/
29. exp Eczema/ or eczema.mp.
30. exp Rhinitis/
31. hayfever.mp.
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32. exp Hay fever/
33. rhinoconjunctivitis.mp.
34. exp Food hypersensitivity/ or food allergy.mp.
35. exp Anaphylaxis/
36. anaphylactic.mp.
37. urticaria*
38. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
or 33 or 34 or 35 or 36 or 37
39. 15 and 21 and 38
APPENDIX 2: Data Extraction Form
General Information
Reviewer
Date of data extraction
Author
Article title
Source (e.g., Journal) Year/ Volume/ Pages/ Country of origin)
Contact email
Study design
Study aim
Quality assessment
Population characteristics
Cohort
Sources of subjects
Inclusion criteria
Exclusion criteria
Recruitment procedures used
Total number of participants recruited
Total number of participants eligible for study data collection
Total number of participants responded
Total number of mother-child pairs to complete follow up
Characteristics of cohort group
- Age
- Geographical region
- Socio-economic status
- Ethnicity
- High risk (family history)
- Setting
- Others
Methods of follow up
Length of follow up
Maternal Exposure
Type of stress/stresses:
- Natural disaster (state which)
- Bereavement
- Work stress
- Divorce or separation
- Financial problem (including involuntary redundancy)
- Exposure to violence
- Anxiety symptoms
- Depression symptoms
- Other
Method of assessment of exposure:
- Method of assessment
- Objective or subjective?
- If questionnaire or scale validated?
Trimester in which exposure measured
- 1st (week 1–13)
- 2nd (week 14–26)
- 3rd (week 27–40+)
- Other
Outcomes
For all outcomes state:
- N/A if not included in paper outcomes
Asthma as an outcome:
- Y/N
- Age or ages at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale validated?
Frequency of asthma exacerbations
Use of asthma medication:
- If yes state which
Hospitalisation for asthma
Airway function test:
- Peak Expiratory Flow (PEF)
- Forced Expiratory Volume in 1 s
- Forced Vital Capacity (FVC)
- Forced Expiratory Flow Rate
- Oscillometry
- Exhaled Nitric Oxide
- Other
Atopic dermatitis/ecezema as an outcome:
- Y/N
- Age of age ranges at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale validated?
Atopic sensitisation as an outcome:
- Y/N
- Age or age range at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale validated?
Food allergy:
- Age or age range at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale validated?
Allergic rhinitis as an outcomes:
- Y/N
- Age or age range at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale, validated?
Urticaria as an outcome:
- Y/N
- Age or age range at which assessed
- Method of assessment
- Objective or subjective?
If questionnaire or scale, validated?
Anaphylaxis as an outcome:
- Y/N
- Age or age range at which assessed
- Method of assessment
- Objective or subjective?
- If questionnaire or scale, validated?
Primary outcomes:
- No of cases in study population (%)
- No of cases amongst exposed (%)
Estimates of association between maternal stress and primary
outcome:
- HR/RR/OR/other
- Crude estimates (95% CI)
- Adjusted estimates
- (95% CI)
- P-value
Secondary outcomes:
- No of cases in study population (%)
- No of cases amongst exposed (%)
Estimates of association between maternal stress and secondary
outcome(s):
- OR/RR/other
- Crude estimates
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- Adjusted estimates
- (95%) CI
- P-value
Missing data:
- No lost to follow up and/or incomplete data
- How was it dealt with in analysis
Analysis
Apriori power calculation
Method of analysis
Statisical software
Subgroup analysis
Additional analyses results not extracted
Confounders included
Mediators Included
Quality Assessment grade for:
- appropriateness of study design
- selection bias
- outcome assessment
- exposure assessment
- confounder assessment -
- appropriateness of statistical analysis
- overall grading
Extra useful information
Limitations
Interpretation
Generalisibility
Funding
Other
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